Cite

HARVARD Citation

    Pickin, D. et al. (1999). Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment. Heart. 82 (3), pp. 325-332. [Online]. 
  
Back to record